Revance Therapeutics Inc
FDA-inspected organization
Revance Therapeutics Inc has been audited by the FDA 4 times between 2021 and 2022 across all 3 sites.
Documents
$995

FDA 483 Revance Therapeutics Inc, Newark | 2021
Out of stock

FDA 483 Revance Therapeutics Inc, Nashville | 2021
Out of stock
